Association between central nervous system stimulants used to treat attention deficit hyperactivity disorder (ADHD) and Raynaud's phenomenon: a scoping review

Michael Hughes

doi:10.1016/j.semarthrit.2021.09.002

Association between central nervous system stimulants used to treat attention deficit hyperactivity disorder (ADHD) and Raynaud's phenomenon: a scoping review

Division of Musculoskeletal & Dermatological Sciences (L5)

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Seminars in arthritis and rheumatism
DOIs	https://doi.org/10.1016/j.semarthrit.2021.09.002
Publication status	Published - Sept 2021

Access to Document

10.1016/j.semarthrit.2021.09.002

Cite this

@article{fc77df23829b4485b802d1e5c37b2b53,

title = "Association between central nervous system stimulants used to treat attention deficit hyperactivity disorder (ADHD) and Raynaud's phenomenon: a scoping review",

author = "Michael Hughes",

year = "2021",

month = sep,

doi = "10.1016/j.semarthrit.2021.09.002",

language = "English",

journal = "Seminars in arthritis and rheumatism",

issn = "0049-0172",

publisher = "W.B. Saunders Company",

}

TY - JOUR

T1 - Association between central nervous system stimulants used to treat attention deficit hyperactivity disorder (ADHD) and Raynaud's phenomenon: a scoping review

AU - Hughes, Michael

PY - 2021/9

Y1 - 2021/9

UR - http://dx.doi.org/10.1016/j.semarthrit.2021.09.002

U2 - 10.1016/j.semarthrit.2021.09.002

DO - 10.1016/j.semarthrit.2021.09.002

M3 - Article

SN - 0049-0172

JO - Seminars in arthritis and rheumatism

JF - Seminars in arthritis and rheumatism

ER -

Association between central nervous system stimulants used to treat attention deficit hyperactivity disorder (ADHD) and Raynaud's phenomenon: a scoping review

Access to Document

Other files and links

Cite this